RWP
AZN icon

RWA Wealth Partners’s AstraZeneca AZN Stock Holding History

RWA Wealth Partners’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.61M Buy
45,390
+3,144
+7% +$591K 0.08% 126
2026
Q1 		$8.33M Buy
42,246
+334
+0.8% +$64.4K 0.09% 118
2025
Q4 		$7.71M Buy
41,912
+10,945
+35% +$1.92M 0.08% 133
2025
Q3 		$4.75M Buy
30,967
+3,222
+12% +$488K 0.05% 179
2025
Q2 		$3.88M Buy
27,745
+2,171
+8% +$304K 0.05% 184
2025
Q1 		$3.76M Buy
25,574
+6,657
+35% +$963K 0.05% 175
2024
Q4 		$2.48M Sell
18,917
-896
-5% -$125K 0.03% 223
2024
Q3 		$3.09M Buy
19,813
+18,122
+1,072% +$2.93M 0.04% 209
2024
Q2 		$264K Hold
1,691
– – ﹤0.01% 481
2024
Q1 		$229K Buy
1,691
+52
+3% +$6.89K ﹤0.01% 505
2023
Q4 		$221K Buy
+1,639
New +$213K ﹤0.01% 494

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

RWA Wealth Partners's AZN Position: Q2 2026 in Review

RWA Wealth Partners increased its AstraZeneca (AZN) stake by 7.4% in Q2 2026, buying an estimated $591K and bringing the position to 45,390 shares worth $8.61M. The position accounts for 0.08% of the portfolio, ranked #126.

RWA Wealth Partners first reported a position in AZN in Q4 2023 and has held it in 11 quarters since. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • RWA Wealth Partners held 45,390 shares of AstraZeneca worth $8.61M as of Q2 2026.
  • RWA Wealth Partners bought 3,144 AstraZeneca shares in Q2 2026, an estimated $591K.
  • AstraZeneca made up 0.08% of RWA Wealth Partners's portfolio in Q2 2026, its #126 holding.
  • RWA Wealth Partners first reported a position in AstraZeneca in Q4 2023 and has held it in 11 quarters since.
  • 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on RWA Wealth Partners's 13F filing for Q2 2026, filed 7 Aug 2026.